Alvotech Stock Current Asset
| ALVO Stock | USD 11.82 0.05 0.42% |
Alvotech fundamentals help investors to digest information that contributes to Alvotech's financial success or failures. It also enables traders to predict the movement of Alvotech Stock. The fundamental analysis module provides a way to measure Alvotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Alvotech stock.
As of the 27th of February 2025, Non Current Assets Total is likely to drop to about 610.3 M. In addition to that, Other Current Assets is likely to drop to about 16.2 M. Alvotech | Current Asset |
Alvotech Company Current Asset Analysis
Alvotech's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Alvotech Current Asset Historical Pattern
Today, most investors in Alvotech Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Alvotech's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Alvotech current asset as a starting point in their analysis.
Alvotech Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Alvotech Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Alvotech has a Current Asset of 0.0. This is 100.0% lower than that of the Biotechnology sector and about the same as Health Care (which currently averages 0.0) industry. The current asset for all United States stocks is 100.0% higher than that of the company.
Alvotech Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alvotech's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alvotech could also be used in its relative valuation, which is a method of valuing Alvotech by comparing valuation metrics of similar companies.Alvotech is currently under evaluation in current asset category among its peers.
Alvotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alvotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alvotech's managers, analysts, and investors.Environmental | Governance | Social |
Alvotech Fundamentals
| Return On Asset | -0.0104 | ||||
| Profit Margin | (1.12) % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 4.63 B | ||||
| Shares Outstanding | 301.94 M | ||||
| Shares Owned By Insiders | 64.87 % | ||||
| Shares Owned By Institutions | 6.25 % | ||||
| Number Of Shares Shorted | 398.57 K | ||||
| Price To Sales | 9.02 X | ||||
| Revenue | 91.43 M | ||||
| Gross Profit | 232.52 M | ||||
| EBITDA | (484.86 M) | ||||
| Net Income | (551.73 M) | ||||
| Cash And Equivalents | 128.44 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.08 B | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | (1.22) X | ||||
| Cash Flow From Operations | (312.19 M) | ||||
| Short Ratio | 2.24 X | ||||
| Earnings Per Share | (1.84) X | ||||
| Target Price | 18.83 | ||||
| Number Of Employees | 999 | ||||
| Beta | -0.19 | ||||
| Market Capitalization | 3.55 B | ||||
| Total Asset | 950.09 M | ||||
| Retained Earnings | (2.21 B) | ||||
| Working Capital | (66.11 M) | ||||
| Net Asset | 950.09 M |
About Alvotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alvotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alvotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alvotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Alvotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alvotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alvotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alvotech Stock: Check out Alvotech Piotroski F Score and Alvotech Altman Z Score analysis. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.84) | Revenue Per Share | Quarterly Revenue Growth 4.786 | Return On Assets |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.